[1]
Baker, C. 2000. Hospital ownership, performance, and outcomes: assessing the state-of-the-science. Journal of Nursing Administration. 30, 5 (2000), 227–240.
[2]
Becker, G.S. and Murphy, K.M. 1988. A Theory of Rational Addiction. Journal of Political Economy. 96, 4 (1988), 675–700. DOI:https://doi.org/10.2307/1830469.
[3]
Becker, G.S. and Murphy, K.M. 1988. A Theory of Rational Addiction. Journal of Political Economy. 96, 4 (1988), 675–700.
[4]
Berwick, D.M. and Weinstein, M.C. 1985. What Do Patients Value? Willingness to Pay for Ultrasound in Normal Pregnancy. Medical Care. 23, 7 (1985), 881–893. DOI:https://doi.org/10.2307/3764800.
[5]
Blendon, R.J. et al. 2003. Common Concerns Amid Diverse Systems: Health Care Experiences In Five Countries. Health Affairs. 22, 3 (2003), 106–121. DOI:https://doi.org/10.1377/hlthaff.22.3.106.
[6]
Card, D. et al. 2009. Does Medicare Save Lives? Quarterly Journal of Economics. 124, 2 (2009), 597–636. DOI:https://doi.org/10.1162/qjec.2009.124.2.597.
[7]
Card, D. et al. 2009. Does Medicare Save Lives? The Quarterly journal of economics. 124, 2 (2009), 597–636. DOI:https://doi.org/10.1162/qjec.2009.124.2.597.
[8]
Cox [et al.], B.D. and Health Promotion Research Trust 1987. The Health and lifestyle survey: preliminary report of a nationwide  survey of the physical and mental health, attitudes and lifestyle of a random sample of 9,003 British adults. Health Promotion Research Trust.
[9]
Cutler, D.M. et al. 2006. The Value of Medical Spending in the United States, 1960–2000. New England Journal of Medicine. 355, (2006), 920–927. DOI:https://doi.org/10.1056/NEJMsa054744.
[10]
Cutler, D.M. et al. 2006. The Value of Medical Spending in the United States, 1960-2000. The New England journal of medicine. 355, (2006), 920–927. DOI:https://doi.org/10.1056/NEJMsa054744.
[11]
Cutler, D.M. and McClellan, M. 2001. Is Technological Change In Medicine Worth It? Health Affairs. 20, 5 (2001), 11–29. DOI:https://doi.org/10.1377/hlthaff.20.5.11.
[12]
Cutler, D.M. and Richardson, E. The Value of Health: 1970-1990. The American Economic Review. 88, 2, 97–100. DOI:https://doi.org/10.2307/116900.
[13]
Cutler, D.M. and Richardson, E. 1998. The Value of Health: 1970-1990. American Economic Review. 88, 2 (1998), 97–100.
[14]
Cutler, D.M. and Zeckhauser, R.J. Adverse Selection in Health Insurance. NBER Working Papers. No. 6107. DOI:https://doi.org/10.3386/w6107.
[15]
Finkelstein, A. and McGarry, K. 2006. Multiple Dimensions of Private Information: Evidence from the Long-Term Care Insurance Market. The American Economic Review. 96, 4 (2006), 938–958. DOI:https://doi.org/10.2307/30034325.
[16]
Finkelstein, A. and McGarry, K. 2008. Multiple Dimensions of Private Information: Evidence from the Long-Term Care Insurance Market. American Economic Review. 96, 4 (2008), 938–958.
[17]
Foster, M. and Jones, A.M. 2001. The Role of Tobacco Taxes in Starting and Quitting Smoking: Duration Analysis of British Data. Discussion Papers in Economics (The University of York-Department of Economics and Related Studies, 2001).
[18]
Hatziandreu, E. et al. 1988. A Cost-Effectiveness Analysis of Exercise as a Health Promotion Activity. American Journal of Public Health. 78, 11 (1988), 1417–1423.
[19]
Hickson, K. 2012. The GDP Value of Twentieth-Century Health Improvements in Developed Economies: Initial Estimates for England. Review of Income and Wealth. 60, 2 (2012), 385–399. DOI:https://doi.org/10.1111/j.1475-4991.2012.00524.x.
[20]
Hirth, R.A. et al. 2000. Willingness to Pay for a Quality-adjusted Life Year. Medical Decision Making. 20, 3 (2000), 332–342. DOI:https://doi.org/10.1177/0272989X0002000310.
[21]
Hirth, R.A. et al. 2000. Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard. Medical Decision Making. 20, 3 (2000), 332–342. DOI:https://doi.org/10.1177/0272989X0002000310.
[22]
Hutton, J. and Brown, R.E. 2002. Use of Economic Evaluation in Decision Making: What Needs to Change? Value in Health. 5, 2 (2002), 65–66. DOI:https://doi.org/10.1046/j.1524-4733.2002.52115.x.
[23]
Leonard, K.L. 2003. African traditional healers and outcome-contingent contracts in health care. Journal of Development Economics. 71, 1 (2003), 1–22. DOI:https://doi.org/10.1016/S0304-3878(02)00131-1.
[24]
Morris, S. 2012. Economic analysis in health care. John Wiley & Sons.
[25]
Morris, S. 2012. Economic analysis in health care. John Wiley & Sons.
[26]
Morris, S. 2012. Economic analysis in health care. John Wiley & Sons.
[27]
Morris, S. 2012. Economic analysis in health care. John Wiley & Sons.
[28]
Morris, S. 2012. Economic analysis in health care. John Wiley & Sons.
[29]
Newhouse, J.P. Free for all? : lessons from the Rand Health Insurance experiment.
[30]
Newhouse, J.P. 1977. Medical Care Expenditure: A Cross National Survey. The Journal of Human Resources. 12, 1 (1977), 115–125.
[31]
Newhouse, J.P. 1977. Medical-Care Expenditure: A Cross-National Survey. The Journal of Human Resources. 12, 1 (1977), 115–125. DOI:https://doi.org/10.2307/145602.
[32]
Nordhaus, W.D. 2002. The Health of Nations: The Contribution of Improved Health to Living Standards. NBER Working Papers. 8818 (2002). DOI:https://doi.org/10.3386/w8818.
[33]
Nordhaus, W.D. 2002. The Health of Nations: The Contribution of Improved Health to Living Standards. NBER Working Papers. No 8818 (2002). DOI:https://doi.org/10.3386/w8818.
[34]
Normand, C. Economics, Health, And The Economics Of Health. BMJ: British Medical Journal. 303, 6817, 1572–1577. DOI:https://doi.org/10.2307/29714045.
[35]
Normand, C. 1991. Economics, Health, and the Economics of Health. BMJ : British medical journal. British medical journal. 303, 6817 (1991), 1572–1577. DOI:https://doi.org/10.1136/bmj.303.6817.1572.
[36]
O’brien, B. 1996. Economic Evaluation of Pharmaceuticals: Frankenstein’s Monster or Vampire of Trials? Medical Care. 34, 12 (1996), 99–108. DOI:https://doi.org/10.2307/3766358.
[37]
O’brien, B. 1996. Economic Evaluation of Pharmaceuticals: Frankenstein’s Monster or Vampire of Trials? Medical Care. 34, 12 (1996), DS99–DS108.
[38]
Oeppen, J. and Vaupel, J.W. Broken Limits to Life Expectancy. Science. 296, 5570. DOI:https://doi.org/10.2307/3076677.
[39]
Oeppen, J. and Vaupel, J.W. 2002. Broken Limits to Life Expectancy. Science. 296, 5570 (2002), 1029–1031.
[40]
Phelps, Charles E. 2003. Health economics. Addison Wesley.
[41]
Propper, C. and Green, K. 2001. A larger role for the private sector in financing UK health care: The arguments and the evidence. Journal of Social Policy. 30, 4 (2001), 685–704.
[42]
Propper, C. and Green, K. 2001. A Larger Role for the Private Sector in Financing UK Health Care: the Arguments and the Evidence. Journal of social policy. 30, 4 (2001), 685–704.
[43]
Saffer, H. 1991. Alcohol advertising bans and alcohol abuse: An international perspective. Journal of Health Economics. 10, 1 (1991), 65–79. DOI:https://doi.org/0167-6296(91)90017-H.
[44]
Schulman, K.A. et al. 1996. Economic Assessment within the Clinical Development Program. Medical Care. 34, 12 (1996), 89–95. DOI:https://doi.org/10.2307/3766357.
[45]
Schulman, K.A. et al. 1996. Economic Assessment within the Clinical Development Program. Medical Care. 34, 12 (1996), DS89–DS95.
[46]
Smith, P. 2009. Performance measurement for health system improvement: experiences, challenges and prospects. Cambridge University Press.
[47]
Smith, P. 2009. Performance measurement for health system improvement: experiences, challenges and prospects. Cambridge University Press.
[48]
Smith, P.C. et al. 2010. Performance Measurement for Health System Improvement: Experiences, Challenges and Prospects. Cambridge University Press.
[49]
Smith, P.C. et al. 2010. Performance Measurement for Health System Improvement: Experiences, Challenges and Prospects. Cambridge University Press.
[50]
Tengs, T.O. et al. 1995. Five-Hundred Life-Saving Interventions and Their Cost-Effectiveness. Risk Analysis. 15, 3 (1995), 369–390. DOI:https://doi.org/10.1111/j.1539-6924.1995.tb00330.x.
[51]
Tussing, A.D. and Wojtowycz, M.A. 1986. Physician-induced demand by Irish GPs. Social Science & Medicine. 23, 9 (1986), 851–860. DOI:https://doi.org/0277-9536(86)90213-3.
[52]
Tussing, A.D. and Wojtowycz, M.A. 1986. Physician-induced demand by Irish GPs. Social Science & Medicine. 23, 9 (1986), 851–860. DOI:https://doi.org/10.1016/0277-9536(86)90213-3.
[53]
Viscusi, W.K. and Aldy, J.E. 2003. The Value of a Statistical Life: A Critical Review of Market Estimates throughout the World. NBER Working Papers. No. 9487 (2003). DOI:https://doi.org/10.3386/w9487.
[54]
Walley, T. and Haycox, A. 1997. Pharmacoeconomics: basic concepts and terminology. British Journal of Clinical Pharmacology. 43, 4 (1997), 343–348. DOI:https://doi.org/10.1046/j.1365-2125.1997.00574.x.
[55]
Walley, T. and Haycox, A. 1997. Pharmacoeconomics: Basic Concepts and Terminology. British journal of pharmacology. 43, 4 (1997), 343–347.
[56]
Woolhandler, S. et al. 2003. Costs of Health Care Administration in the United States and Canada. The New England journal of medicine. 349, 8 (2003), 768–775. DOI:https://doi.org/10.1056/NEJMsa022033.
[57]
Woolhandler, S. et al. 2003. Costs of Health Care Administration in the United States and Canada. The New England journal of medicine. 349, 8 (2003), 768–775. DOI:https://doi.org/10.1056/NEJMsa022033.
[58]
Journal of health economics.